303 related articles for article (PubMed ID: 21416150)
1. Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.
Dolan BP; Bennink JR; Yewdell JW
Cell Mol Life Sci; 2011 May; 68(9):1481-9. PubMed ID: 21416150
[TBL] [Abstract][Full Text] [Related]
2. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.
Yewdell JW
Trends Immunol; 2011 Nov; 32(11):548-58. PubMed ID: 21962745
[TBL] [Abstract][Full Text] [Related]
3. MHC class I antigen presentation of DRiP-derived peptides from a model antigen is not dependent on the AAA ATPase p97.
Palmer AL; Dolan BP
PLoS One; 2013; 8(7):e67796. PubMed ID: 23844095
[TBL] [Abstract][Full Text] [Related]
4. Re-examining class-I presentation and the DRiP hypothesis.
Rock KL; Farfán-Arribas DJ; Colbert JD; Goldberg AL
Trends Immunol; 2014 Apr; 35(4):144-52. PubMed ID: 24566257
[TBL] [Abstract][Full Text] [Related]
5. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?
Yewdell JW; Antón LC; Bennink JR
J Immunol; 1996 Sep; 157(5):1823-6. PubMed ID: 8757297
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
[TBL] [Abstract][Full Text] [Related]
7. Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway.
Antoniou AN; Powis SJ
Immunology; 2008 May; 124(1):1-12. PubMed ID: 18284468
[TBL] [Abstract][Full Text] [Related]
8. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond.
Lilley BN; Ploegh HL
Immunol Rev; 2005 Oct; 207():126-44. PubMed ID: 16181332
[TBL] [Abstract][Full Text] [Related]
9. Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors.
Antón LC; Yewdell JW
J Leukoc Biol; 2014 Apr; 95(4):551-62. PubMed ID: 24532645
[TBL] [Abstract][Full Text] [Related]
10. The DRiP hypothesis decennial: support, controversy, refinement and extension.
Yewdell JW; Nicchitta CV
Trends Immunol; 2006 Aug; 27(8):368-73. PubMed ID: 16815756
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation.
Palmer AL; de Jong A; Leestemaker Y; Geurink PP; Wijdeven RH; Ovaa H; Dolan BP
J Immunol; 2018 Feb; 200(3):928-936. PubMed ID: 29282303
[TBL] [Abstract][Full Text] [Related]
12. Involvement of autophagy in MHC class I antigen presentation.
Øynebråten I
Scand J Immunol; 2020 Nov; 92(5):e12978. PubMed ID: 32969499
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic processing of peptides in the lumen of the endoplasmic reticulum for antigen presentation by major histocompatibility class I.
Lobigs M; Chelvanayagam G; Müllbacher A
Eur J Immunol; 2000 May; 30(5):1496-506. PubMed ID: 10820398
[TBL] [Abstract][Full Text] [Related]
14. Role of genetic variations on MHC class I antigen-processing genes in human cancer and viral-mediated diseases.
D'Alicandro V; Romania P; Melaiu O; Fruci D
Mol Immunol; 2019 Sep; 113():11-15. PubMed ID: 29625843
[TBL] [Abstract][Full Text] [Related]
15. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway.
Früh K; Gruhler A; Krishna RM; Schoenhals GJ
Immunol Rev; 1999 Apr; 168():157-66. PubMed ID: 10399072
[TBL] [Abstract][Full Text] [Related]
16. RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis?
Dolan BP; Knowlton JJ; David A; Bennink JR; Yewdell JW
J Immunol; 2010 Dec; 185(11):6728-33. PubMed ID: 21048111
[TBL] [Abstract][Full Text] [Related]
17. Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus.
Powers CJ; Früh K
PLoS Pathog; 2008 Oct; 4(10):e1000150. PubMed ID: 18833297
[TBL] [Abstract][Full Text] [Related]
18. MHC I chaperone complexes shaping immunity.
Thomas C; Tampé R
Curr Opin Immunol; 2019 Jun; 58():9-15. PubMed ID: 30771631
[TBL] [Abstract][Full Text] [Related]
19. Flu DRiPs in MHC Class I Immunosurveillance.
Wei J; Yewdell JW
Virol Sin; 2019 Apr; 34(2):162-167. PubMed ID: 30456657
[TBL] [Abstract][Full Text] [Related]
20. New insights into the structure of the MHC class I peptide-loading complex and mechanisms of TAP inhibition by viral immune evasion proteins.
Praest P; Liaci AM; Förster F; Wiertz EJHJ
Mol Immunol; 2019 Sep; 113():103-114. PubMed ID: 29606337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
